スパズモディックエントロピオンにおけるボツリヌム神経毒A注射:臨床復元コホート研究
Brigitte Girard1,2,3, Fabienne Carré3,4, Simon Begnaud1,2,5,6
1Ophthalmology Department, Tenon Hospital, AP-HP, 4 rue de la Chine, 75020 Paris, France.
Toxins
|August 27, 2025
まとめ
ボトリヌム神経毒A (BoNT) は,老年患者における性エントロピオンに対する手術に安全で効果的な代替薬です. この治療は症状を迅速に緩和し,生活質を向上させるため,再注射は頻繁に行われません.
科学分野:
- 眼科について
- 神経科学
背景:
- 手術は 性エントロピオンの標準です
- 脆弱な高齢者は 手術に適さないかもしれません
研究 の 目的:
- 老年患者における性エントロピオンの代替治療としてボトリン神経毒素A (BoNT) を評価する.
- 詳細に BoNT 治療パターン,投与量,有効性,および合併症.
主な方法:
- スパズモディック・エントロピオンを持つ50人の高齢者のコホート研究.
- 患者はインコボトゥリニウム,オナボトゥリニウム,またはアボボトゥリニウムを注射された.
- BoNTの投与量,再注射頻度,解消時間,合併症に関するデータ
主要な成果:
- スパズモディックエントロピオンは注射後3日以内に解消した.
- 平均再注射間隔は4. 25ヶ月でした.
- BoNT型と再注射間隔との間には統計的に有意な関係が見つかりませんでした.
- BoNT治療に対する患者の有意な反応が観察されました.
- 組織的な合併症は報告されていません.
結論:
- ボトリヌム神経毒Aは,脆弱な高齢者の性エントロピオンの安全で効果的な治療法です.
- BoNTは手術の代替手段として,または一時的な手段として使用できます.
関連する概念動画
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
751
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
751
Skeletal Muscle Relaxants: Therapeutic Uses
612
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
612
Open Angle Glaucoma: Treatment
557
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
557
Angle Closure Glaucoma: Treatment
669
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
669


